With recent regulatory changes making annuities more accessible within 401(k) plans, many mid-career savers are weighing the pros and cons of these guaranteed income products. We break down the key considerations.
Regulatory milestones for two AstraZeneca cancer drugs—one in the U.S. and one in Europe—signal momentum for the pharma giant's targeted oncology pipeline, offering new hope for patients with difficult-to-treat cancers.
Shares of iFabric Corp. (TSE:IFA) have delivered a stunning 142% return to investors over the past three years, with a recent surge of 99% in just a quarter. The rally coincides with the company's journey to profitability, though analysts urge a closer look at the long-term trajectory and underlying fundamentals.
Shares of Pharming Group (ENXTAM:PHARM) came under pressure after the U.S. FDA issued a Complete Response Letter for its supplemental filing of Joenja in children with APDS. While the short-term sentiment turned negative, the company's longer-term growth trajectory and valuation gap present a complex picture for investors.
McKesson Corporation's stock has delivered staggering returns, climbing 374% over five years. As shares hover near record highs, analysts are divided: some see continued upside based on cash flow models, while others caution that the easy money may have been made. We examine the valuation debate surrounding this healthcare distribution behemoth.
Following a strong quarterly performance, MINISO Group has unveiled an accelerated global expansion plan and a deepened commitment to its proprietary intellectual property platform, reshaping its growth narrative and investor calculus.
Kyivstar Group's successful secondary offering on Nasdaq has bolstered its war chest, enabling a sharper pivot towards building a digital ecosystem and pursuing strategic acquisitions beyond its core telecom operations.
Freeport-McMoRan's shares have soared on robust earnings and copper demand, but analysts are divided on whether the rally has outpaced the miner's fundamental value.
D-Wave Quantum (QBTS) shares have soared over 150% since 2025 but are down sharply this year. As the company pivots to a dual-platform strategy, we examine whether its niche technology and lofty valuation signal opportunity or excessive risk in the nascent quantum computing race.
Financial guru Robert Kiyosaki challenges the notion that retirement marks the end of earning potential, outlining four practical 'encore career' paths for seniors to generate income and find renewed purpose.
Amid renewed scrutiny from recently unsealed court documents, the Duke of York has vacated his Windsor home ahead of schedule and moved to the King's Sandringham estate, marking a significant retreat from public life as legal and reputational pressures mount.
Indian Hotels Company (IHCL) has inked a strategic framework agreement with the Rajdarbar Group to develop seven new Ginger hotels across North India, adding over 1,000 rooms to its portfolio and capitalizing on strong demand in tier-2 cities and commercial hubs.
Global agribusiness giant Bunge Ltd. reported stronger-than-expected fourth-quarter earnings, driven by robust performance across its diversified portfolio, outpacing Wall Street projections.
Bitwise's Matt Hougan argues the crypto market entered a bear phase at the start of 2025, a reality obscured by massive institutional buying. The debate now centers on when the thaw will begin.
As the STOXX Europe 600 inches higher, a subset of investors is turning their gaze to the market's smallest players. We examine three European companies with market capitalizations under €8 million, assessing their potential and pitfalls in a complex economic landscape.
After a meteoric post-IPO rise and an 80% collapse, Figma's future hangs in the balance. We analyze whether its robust product and growing enterprise base justify its still-lofty valuation.
Two digital banking disruptors, Nu Holdings in Latin America and SoFi Technologies in the U.S., have seen their stock prices skyrocket over the past three years. We analyze their trajectories, market potential, and which might offer investors a stronger runway ahead.
UBS Group reported a 62% surge in underlying pre-tax profit for Q4 2025, driven by revenue momentum and cost discipline. The bank is nearing its post-merger targets but cautions that unlocking the final tranche of savings hinges on completing Swiss client migrations.
As Robinhood shares tumble nearly 40% from their peak, star investor Cathie Wood's ARK Invest has made a multimillion-dollar wager, betting that potential policy shifts could reignite the trading platform's long-term growth story.
Despite a recent 21% monthly share price decline, Ares Management (NYSE: ARES) has delivered a 167% total return to shareholders over five years. Analysts point to a disconnect between robust earnings growth and recent market sentiment, suggesting potential undervaluation.
